These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1897376)

  • 21. [Sleep in anorexia nervosa, bulimia nervosa and depressive diseases: a polysomnographic comparative study].
    Lauer C; Krieg JC; Zulley J; Riemann D; Berger M
    Fortschr Neurol Psychiatr; 1989 Oct; 57(10):403-10. PubMed ID: 2680843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinergic influence on manic symptoms.
    Krieg JC; Berger M
    Clin Neuropharmacol; 1986; 9 Suppl 4():544-6. PubMed ID: 3567961
    [No Abstract]   [Full Text] [Related]  

  • 23. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.
    Sonntag A; Rothe B; Guldner J; Yassouridis A; Holsboer F; Steiger A
    Depression; 1996; 4(1):1-13. PubMed ID: 9160649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Depression and sleep--the status of current research].
    Riemann D; Schnitzler M; Hohagen F; Berger M
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):458-78. PubMed ID: 7835818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cholinergic agonist RS 86: a pharmacopsychological study.
    Fritze J; Beckmann H
    Neuropsychobiology; 1988; 19(1):35-9. PubMed ID: 3054624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
    Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
    Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
    Gallagher P; Watson S; Elizabeth Dye C; Young AH; Nicol Ferrier I
    J Psychiatr Res; 2008 Oct; 42(12):1037-41. PubMed ID: 18255098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinomimetic drug RS 86, REM sleep, and depression.
    Berger M; Höchli D; Zulley J; Lauer C; von Zerssen D
    Lancet; 1985 Jun; 1(8442):1385-6. PubMed ID: 2861327
    [No Abstract]   [Full Text] [Related]  

  • 29. EEG sleep in Cushing's disease and Cushing's syndrome: comparison with patients with major depressive disorder.
    Shipley JE; Schteingart DE; Tandon R; Pande AC; Grunhaus L; Haskett RF; Starkman MN
    Biol Psychiatry; 1992 Jul; 32(2):146-55. PubMed ID: 1330006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cholinergic REM induction test with RS 86 after scopolamine pretreatment in healthy subjects.
    Riemann D; Hohagen F; Fleckenstein P; Schredl M; Berger M
    Psychiatry Res; 1991 Sep; 38(3):247-60. PubMed ID: 1754637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects.
    Hollander E; Davidson M; Mohs RC; Horvath TB; Davis BM; Zemishlany Z; Davis KL
    Biol Psychiatry; 1987 Sep; 22(9):1067-78. PubMed ID: 3651528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.
    Schmid DA; Brunner H; Lauer CJ; Uhr M; Yassouridis A; Holsboer F; Friess E
    J Psychiatr Res; 2008 Oct; 42(12):991-9. PubMed ID: 18226817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring cholinergic sensitivity: I. Arecoline effects in bipolar patients.
    Nurnberger J; Berrettini W; Mendelson W; Sack D; Gershon ES
    Biol Psychiatry; 1989 Mar; 25(5):610-7. PubMed ID: 2920194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of the development of a first major depressive episode with a rapid eye movement sleep induction test using the cholinergic agonist RS 86.
    Lauer CJ; Modell S; Schreiber W; Krieg JC; Holsboer F
    J Clin Psychopharmacol; 2004 Jun; 24(3):356-7. PubMed ID: 15118498
    [No Abstract]   [Full Text] [Related]  

  • 35. A polysomnographic study in young psychiatric inpatients: major depression, anorexia nervosa, bulimia nervosa.
    Lauer CJ; Krieg JC; Riemann D; Zulley J; Berger M
    J Affect Disord; 1990 Apr; 18(4):235-45. PubMed ID: 2140375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinergic REM sleep induction by arecoline in normal subjects: relation to thyroid function.
    Keshavan M; Dubé S; Grabowski J; Sitaram N
    Psychiatry Res; 1988 Jun; 24(3):333-6. PubMed ID: 3406243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. REM sleep and cortisol responses to scopolamine during depression and remission in women.
    Rao U; Lin KM; Schramm P; Poland RE
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):265-74. PubMed ID: 15132761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of supersensitive cholinergic REM-induction and affective illness within pedigrees.
    Sitaram N; Dube S; Keshavan M; Davies A; Reynal P
    J Psychiatr Res; 1987; 21(4):487-97. PubMed ID: 3440958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers.
    Nissen C; Nofzinger EA; Feige B; Waldheim B; Radosa MP; Riemann D; Berger M
    Neuropsychopharmacology; 2006 Jun; 31(6):1294-300. PubMed ID: 16192980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.